ALPN - ALPINE IMMUNE SCIENCES, INC.
Close
64.985
64.985 100.000%
Share volume: 0
Last Updated: Fri 17 May 2024 07:59:58 PM CEST
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
23%
Profitability
25%
Dept financing
10%
Liquidity
48%
Performance
18%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.1%
Return on assets
-6.87%
Return on sales
-246.86%
Return on invested capital
54.2%
Total debt ratio
50.33%
Debt ratio change over timeo
-0.54%
Current Ratio
3.55%
Quick Ratio
3.17%
Cash Position Ratio
3.07%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.34%
Return on assets
-6.32%
Return on sales
-306.73%
Return on invested capital
60.47%
Total debt ratio
34.64%
Debt ratio change over timeo
-0.6%
Current Ratio
3.83%
Quick Ratio
3.83%
Cash Position Ratio
3.77%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-7.25%
Return on assets
-6.05%
Return on sales
-144.88%
Return on invested capital
134.95%
Total debt ratio
32.81%
Debt ratio change over time
-0.76%
Current Ratio
3.81%
Quick Ratio
3.81%
Cash Position Ratio
3.73%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-109.15%
Return on assets
-105.83%
Return on sales
-386.35%
Return on invested capital
8.9%
Total debt ratio
-54.32%
Debt ratio change over time
-0.54%
Current Ratio
1.78%
Quick Ratio
2.96%
Cash Position Ratio
1.69%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALPN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -16.1% | 0% | 0% | -117.6% |
| Return on assets | -6.87% | 0% | 0% | -11.99% |
| Return on sales | -246.86% | 0% | 0% | -8680.79% |
| Return on invested capital | 54.2% | 0% | 0% | -48.11% |
| Profitability | 25% | 0% | 75% | 0% |
| Total debt ratio | 50.33% | 0% | 0% | 77.42% |
| Debt ratio change over time | -0.54% | 0% | 0% | -0.81% |
| Dept financing | 16% | 0% | 25% | 25% |
| Current Ratio | 3.83% | 0% | 0% | 5.35% |
| Quick Ratio | 3.83% | 0% | 0% | 5.34% |
| Cash Position Ratio | 3.77% | 0% | 0% | 5.03% |
| Liquididy | 31% | 0% | 0% | 75% |
| Short-term ratios | ALPN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -8.34% | 0% | 0% | 146.7% |
| Return on assets | -6.32% | 0% | 0% | -18.66% |
| Return on sales | -306.73% | 0% | 0% | -28500.29% |
| Return on invested capital | 60.47% | 0% | 0% | -371.75% |
| Profitability | 25% | 0% | 50% | 25% |
| Total debt ratio | 34.64% | 0% | 0% | 108.07% |
| Debt ratio change over time | -0.6% | 0% | 0% | -1.53% |
| Dept financing | 8% | 0% | 25% | 25% |
| Current Ratio | 3.83% | 0% | 0% | 5.35% |
| Quick Ratio | 3.83% | 0% | 0% | 5.34% |
| Cash Position Ratio | 3.77% | 0% | 0% | 5.03% |
| Liquididy | 55% | 0% | 0% | 75% |